Biosimilars-2013 Report

2^nd International Conference and Exhibition on Biowaivers & Biosimilars was successfully organized by OMICS Group on September 23-25, 2013 at Raleigh, North Carolina, USA. Outstanding response and active participation was received from the researchers, leaders from regulatory, pharmaceutical R&D sectors, and principal investigators. Organizing Committee Members & Editorial Board Members of OMICS Group helped in making this meeting a grand success.

The theme of this event “Addressing Novel Strategic Considerations for Biosimilar Market” covered a broad range of vitally important sessions that covered the way to exchange ideas and perspectives on the challenges in this field.

The conference proved to be the most important gathering for Pharma leaders, in competing to bring affordable medicines to market and establishment of insightful case studies and in-depth market analysis for the fast-growing of Biosimilars.  

Keynote sessions were preceded by eminent speakers:

Dr. Michael Retsky, Harvard School of Public Health, USA
Dr. Ivo Abraham, University of Arizona, USA
Dr. Russell Reeve, Quintiles Inc., USA
Dr. Arturo Solis Herrera, Human Photosynthesis Study Center, Mexico
Dr. Rodeina Challand, PRA International, UK

OMICS Group International conveys its wishes for the support of various organizations and delegates from all around the world. And our sincere admiration to our Event exhibitor: FeF Chemicals for their determined efforts towards manufacturing and supply high purity products, and BioPort Folio (USA), ChemLinked (China) & Lab Bulletin (USA) for its efforts in promoting this event throughout its network.

With grand success of Biosimilars-2013 in USA, OMICS Group International is proud to announce "3^rd International Conference and Exhibition on Biowaivers & Biosimilars” during October 27-29, 2014 in Hyderabad, India.

Coming together is a beginning; keeping together is progress; working together is success.

We wish to lead a way to a fabulous event.